Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis

অনুরূপ উপাদানগুলি

• High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic/myeloproliferative neoplasms
  অনুযায়ী: Jeromin, Sabine, অন্যান্য
  প্রকাশিত: (2013)
• Refractory anemia with ring sideroblasts and thrombocytosis
  অনুযায়ী: Pradhan, Sarita
  প্রকাশিত: (2017)
• Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations
  অনুযায়ী: Jeromin, Sabine, অন্যান্য
  প্রকাশিত: (2015)
• Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis
  অনুযায়ী: Broseus, Julien, অন্যান্য
  প্রকাশিত: (2012)
• Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis
  অনুযায়ী: Tefferi, A, অন্যান্য
  প্রকাশিত: (2016)